Literature DB >> 8357773

Hypertensive labeling: does it have therapeutic implications.

W H Birkenhäger.   

Abstract

Screening for hypertension within the proper setting potentially leads to the detection of numerous (mild) hypertensives, some of whom in due time may well qualify for treatment. One disadvantage of the procedure appears to be that hitherto unwitting hypertensives may develop some adverse psychological and physiological phenomena. Behavioral effects seem to be particularly obvious after screening on the worksite, where newly identified hypertensive employees tend to respond with increased absenteeism and allied symptoms of labeling. In the clinical setting, physiological studies in recently informed hypertensives have demonstrated a series of signs of increased sympathetic activity: heart rate, cardiac index, circulating catecholamines, and renin, and even blood pressure itself, tend to be higher in aware vs. unaware young hypertensives. Although some correlations between psychological and physiological sequelae have been observed, the true nature of such links is far from clear. Simple anxiety does not seem to be the main mechanism. Pending further research, the question is discussed as to whether these phenomena are harmful enough to warrant a need for counseling or treatment.

Entities:  

Mesh:

Year:  1993        PMID: 8357773     DOI: 10.1007/bf00878509

Source DB:  PubMed          Journal:  Cardiovasc Drugs Ther        ISSN: 0920-3206            Impact factor:   3.727


  14 in total

1.  Awareness of high blood pressure influences on psychological and sympathetic responses.

Authors:  M Rostrup; O Ekeberg
Journal:  J Psychosom Res       Date:  1992-02       Impact factor: 3.006

Review 2.  Reflections on the impact of antihypertensive medications on mood, sedation, and neuropsychologic functioning.

Authors:  J E Dimsdale
Journal:  Arch Intern Med       Date:  1992-01

3.  Beta-adrenergic blocking therapy in hypertension: selection of patients.

Authors:  E D Frohlich; R C Tarazi; H P Dustan
Journal:  Int Z Klin Pharmakol Ther Toxikol       Date:  1970-12

4.  Labelling and absenteeism: the Massachusetts Mutual experience.

Authors:  M H Alderman; M E Charlson; L A Melcher
Journal:  Clin Invest Med       Date:  1981       Impact factor: 0.825

5.  Longterm follow-up of absenteeism among working men following the detection and treatment of their hypertension.

Authors:  D W Taylor; R B Haynes; D L Sackett; E S Gibson
Journal:  Clin Invest Med       Date:  1981       Impact factor: 0.825

Review 6.  Labeling of participants in high blood pressure screening programs. Implications for blood cholesterol screenings.

Authors:  R C Lefebvre; K G Hursey; R A Carleton
Journal:  Arch Intern Med       Date:  1988-09

7.  Awareness of hypertension increases blood pressure and sympathetic responses to cold pressor test.

Authors:  M Rostrup; S E Kjeldsen; I K Eide
Journal:  Am J Hypertens       Date:  1990-12       Impact factor: 2.689

8.  Consequences of worksite hypertension screening. Differential changes in psychosocial function.

Authors:  P Rudd; M G Price; L E Graham; B A Beilstein; S J Tarbell; P Bacchetti; S P Fortmann
Journal:  Am J Med       Date:  1986-05       Impact factor: 4.965

9.  Effects of labeling and treatment of hypertension on perceived health.

Authors:  L C Harlan; B F Polk; S Cooper; T P Blaszkowski; J Ignatius-Smith; M Stromer; H Mull
Journal:  Am J Prev Med       Date:  1986 Sep-Oct       Impact factor: 5.043

10.  Personality differences between hypertensive and normotensive individuals: influence of knowledge of hypertension status.

Authors:  M J Irvine; D M Garner; M P Olmsted; A G Logan
Journal:  Psychosom Med       Date:  1989 Sep-Oct       Impact factor: 4.312

View more
  1 in total

1.  Hypertensive labeling (reply to Dr. Birkenhäger's editorial)

Authors:  P Lund-Johansen
Journal:  Cardiovasc Drugs Ther       Date:  1993-08       Impact factor: 3.727

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.